Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 13 papers were listed this time. Here's a few in our areas of research interest:
Chan Lee W, Samyshkin Y, Langer J, Palmer JL. Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis. J Med Econ. 2012 Jul 26. [Epub ahead of print] PubMed PMID: 22834986.
Toy M, Onder FO, Idilman R, et al. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country. Eur J Health Econ. 2012 Jul 20. [Epub ahead of print] PubMed PMID: 22815098.
Pfohl M, Schädlich PK, Dippel FW, et al. Health economic evaluation of insulin glargine versus NPH insulin in intensified conventional therapy for type 1 diabetes in Germany. J Med Econ. 2012 Jul 19. [Epub ahead of print] PubMed PMID: 22812690.
